[Effect of therapy on the levels of immunoreactive calcitonin and parathormone in patients with autoimmune thyroiditis].
Altogether 18 female patients and one male patient with autoimmune thyroiditis aged 17 to 57 were investigated before and during thyroidin therapy. A basal raised level of immunoreactive calcitonin (iCT) was revealed in 4 patients, that of immunoreactive parathormone (iPTH) in 11 patients. The authors discussed the causes of the elevation of iCT and iPTH levels in patients with autoimmune thyroiditis. A transient character of a rise of the content of these hormones was noted. The authors suggested that in raised iCT and iPTH levels assessment of C-cell and parathyroid function should be repeated in patients with autoimmune thyroiditis after compensation of the main disease.
Danis
Iu K
IuK
Urbanavichius
V Iu
VIu
Nekrasova
L V
LV
Rutkauskene
A Ch
ACh
D000293:Adolescent; D000328:Adult; D002116:Calcitonin / Q000097:blood* / Q000276:immunology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010281:Parathyroid Hormone / Q000097:blood* / Q000276:immunology; D013960:Thyroid Function Tests; D013963:Thyroid Hormones / Q000627:therapeutic use*; D013967:Thyroiditis, Autoimmune / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy*
D010281:Parathyroid Hormone; D013963:Thyroid Hormones; C004227:thyroidin; D002116:Calcitonin
Vliianie terapii na soderzhanie immunoreaktivnogo kal'tsitonina i paratgormona u bol'nykh autoimmunnym tireoiditom.